You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 17, November 3, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (42)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Viral Infections
 •Aging/ Geriatrics
 •Alert me on articles by topic

Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons

A. C. G. Voordouw, MD; M. C. J. M. Sturkenboom, PhD; J. P. Dieleman, PhD; Th. Stijnen, PhD; D. J. Smith, PhD; J. van der Lei, PhD; Bruno H. Ch. Stricker, MB, PhD

JAMA. 2004;292:2089-2095.

Context  Although large-scale observational studies have demonstrated the effectiveness of influenza vaccination, no large studies have systematically addressed the clinical benefit of annual revaccinations.

Objective  To investigate the effect of annual influenza revaccination on mortality in community-dwelling elderly persons.

Design, Setting, and Participants  A population-based cohort study using the computerized Integrated Primary Care Information (IPCI) database in the Netherlands including community-dwelling individuals aged 65 years or older from 1996 through 2002. For each year, we computed the individual cumulative exposure to influenza vaccination since study start.

Main Outcome Measure  Association between the number of consecutive influenza vaccinations and all-cause mortality vs no vaccination after adjusting for age, sex, chronic respiratory and cardiovascular disease, hypertension, diabetes mellitus, renal failure, and cancer.

Results  The study population included 26 071 individuals, of whom 3485 died during follow-up. Overall, a first vaccination was associated with a nonsignificant annual reduction of mortality risk of 10% (hazard ratio [HR], 0.90; 95% confidence interval [CI], 0.78-1.03) while revaccination was associated with a reduced mortality risk of 24% (HR, 0.76; 95% CI, 0.70-0.83). Compared with a first vaccination, revaccination was associated with a reduced annual mortality risk of 15% (HR, 0.85; 95% CI, 0.75-0.96). During the epidemic periods this reduction was 28% (HR, 0.72; 95% CI, 0.53-0.96). Similar estimates were obtained for persons with and without chronic comorbidity and those aged 70 years or older at baseline. Overall, influenza vaccination is estimated to prevent 1 death for every 302 vaccinees at a vaccination coverage that varied between 64% and 74%.

Conclusion  Annual influenza vaccination is associated with a reduction in all-cause mortality risk in a population of community-dwelling elderly persons, particularly in older individuals.


Author Affiliations: Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology & Biostatistics (Drs Voordouw, Sturkenboom, Dieleman, Stijnen, and Stricker), Department of Medical Informatics (Drs Sturkenboom, Dieleman, and van der Lei), and Department of Virology (Dr Smith), Erasmus University Medical Center, Rotterdam, the Netherlands; Medicines Evaluation Board (Dr Voordouw) and DrugSafety Unit, Inspectorate for Health Care (Dr Stricker), the Hague, the Netherlands; and Department of Zoology, University of Cambridge, Cambridge, England (Dr Smith).


RELATED ARTICLE

Influenza
Janet M. Torpy, Tiffany J. Glass, and Richard M. Glass
JAMA. 2004;292(17):2182.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area
Ortqvist et al.
Eur Respir J 2007;30:414-422.
ABSTRACT | FULL TEXT  

Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia.
Voordouw et al.
Arch Intern Med 2006;166:1980-1985.
ABSTRACT | FULL TEXT  

Interdisciplinary Epidemiologic and Economic Research Needed to Support a Universal Childhood Influenza Vaccination Policy
Coleman et al.
Epidemiol Rev 2006;28:41-46.
ABSTRACT | FULL TEXT  

Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson et al.
Int J Epidemiol 2006;35:337-344.
ABSTRACT | FULL TEXT  

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
Jackson et al.
Int J Epidemiol 2006;35:345-352.
ABSTRACT | FULL TEXT  

A Technical Infrastructure to Conduct Randomized Database Studies Facilitated by a General Practice Research Database
Mosis et al.
J. Am. Med. Inform. Assoc. 2005;12:602-607.
ABSTRACT | FULL TEXT  

Influenza Vaccine Confusion: A Call for an Alternative Evidence-Based Approach
Yogev
Pediatrics 2005;116:1214-1215.
FULL TEXT  

Influenza Vaccination Among Diabetic Adults: Related factors and trend from 1993 to 2001 in Spain
Jimenez-Garcia et al.
Diabetes Care 2005;28:2031-2033.
FULL TEXT  

Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
Longini and Halloran
Am J Epidemiol 2005;161:303-306.
ABSTRACT | FULL TEXT  

Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
Simonsen et al.
Arch Intern Med 2005;165:265-272.
ABSTRACT | FULL TEXT  

Mortality Benefit of Repeat Flu Vaccination in Elders
Journal Watch Cardiology 2004;2004:5-5.
FULL TEXT  

Mortality Benefit of Repeat Flu Vaccination in Elders
JWatch General 2004;2004:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.